These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 16683418)
1. The FDA and the person with cancer: give PROs a chance. Cella D Oncology (Williston Park); 2006 Apr; 20(4):436. PubMed ID: 16683418 [No Abstract] [Full Text] [Related]
2. Trouble at the office. Allison M Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797 [No Abstract] [Full Text] [Related]
10. Pediatric drug development in anesthesiology: an FDA perspective. Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624 [No Abstract] [Full Text] [Related]
11. The right to a trial: Should dying patients have access to experimental drugs? Groopman J New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539 [No Abstract] [Full Text] [Related]
12. Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review: Perspectives From Industry, the Food and Drug Administration, and the Patient. Basch E; Geoghegan C; Coons SJ; Gnanasakthy A; Slagle AF; Papadopoulos EJ; Kluetz PG JAMA Oncol; 2015 Jun; 1(3):375-9. PubMed ID: 26181187 [TBL] [Abstract][Full Text] [Related]
14. Cancer nanotherapeutics in clinical trials. Lytton-Jean AK; Kauffman KJ; Kaczmarek JC; Langer R Cancer Treat Res; 2015; 166():293-322. PubMed ID: 25895874 [TBL] [Abstract][Full Text] [Related]
15. Researchers left to guess at outcomes of most cancer clinical trials. Twombly R J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774 [No Abstract] [Full Text] [Related]
16. Experimental use and the Orphan Drug Act: a biotechnology conundrum. Koivuniemi PJ Nat Biotechnol; 1996 Apr; 14(4):511-2. PubMed ID: 9630930 [No Abstract] [Full Text] [Related]
17. Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop. Frueh FW; Rudman A; Simon K; Gutman S; Reed C; Dorner AJ Pharmacogenomics J; 2006; 6(5):296-300. PubMed ID: 16568150 [No Abstract] [Full Text] [Related]
18. How FDA approves biotechnology drugs. Manuel SM; Piascik P Am Pharm; 1995 May; NS35(5):14-5. PubMed ID: 7611131 [No Abstract] [Full Text] [Related]
19. The needs of the few. Nature; 2010 Jul; 466(7303):160. PubMed ID: 20613796 [No Abstract] [Full Text] [Related]
20. FDA says it's open to new approaches to cancer trials. Traynor K Am J Health Syst Pharm; 2008 May; 65(9):795, 800. PubMed ID: 18436724 [No Abstract] [Full Text] [Related] [Next] [New Search]